Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity

Adv Healthc Mater. 2012 May;1(3):321-5. doi: 10.1002/adhm.201100030. Epub 2012 Mar 27.

Abstract

A nanoreservoir for efficient intracellular anticancer drug delivery based on mesoporous silica nanoparticles end-capped with lactobionic acid-grafted bovine serum albumin is fabricated. It demonstrates great potential for both cell-specific endocytosis and intracellular pH-responsive controlled release of drugs. A possible endocytosis pathway/mechanism of the smart controlled drug release system is proposed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Delayed-Action Preparations / chemical synthesis*
  • Disaccharides / chemistry*
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry*
  • Hep G2 Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Materials Testing
  • Nanocapsules / chemistry*
  • Nanocapsules / ultrastructure
  • Particle Size
  • Porosity
  • Serum Albumin, Bovine / chemistry*
  • Silicon Dioxide / chemistry*
  • Subcellular Fractions / chemistry*

Substances

  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Disaccharides
  • Nanocapsules
  • Serum Albumin, Bovine
  • lactobionic acid
  • Silicon Dioxide
  • Doxorubicin